Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mikio Wanibe"'
Autor:
Yushin Tominaga, N Uchida, Taka Matsumura, H Koga, U Richarz, Mila Etropolski, Mikio Wanibe, A Okamoto, Keiichiro Hirose
Publikováno v:
Drug research. 66(7)
Background: The efficacy of tapentadol extended release (ER) for managing chronic pain has been demonstrated in large-scale, randomized, controlled, phase 3 studies (N=318–1,030) in patients with chronic osteoarthritis (OA) pain, low back pain (LBP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31eb2312ec9ee0a37091f08c6ad20f4f
https://pubmed.ncbi.nlm.nih.gov/27224908
https://pubmed.ncbi.nlm.nih.gov/27224908
Autor:
Soichirou Tsuji, Masaji Sakurai, Toshinaga Watanabe, Mikio Wanibe, Yasuo Nakajima, Mitsuaki Saeki, Shigeru Terajima
Publikováno v:
Drug Delivery System. 17:330-337
More than 2 years have passed since Levovist®, a clinically applicable contrast agent for image diagnosis by intravenous ultrasonography, was approved. After start of the clinical use, there were advances in the ultrasonographic apparatuses, and as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f43cbf477806b7196e64ccedfa4208c1
https://doi.org/10.2745/dds.17.330
https://doi.org/10.2745/dds.17.330
Autor:
Keiichiro Hirose, Mikio Wanibe, Keiichiro Imanaka, Masaki Ohsaka, Taka Matsumura, Ilse Van Hove, Yushin Tominaga, Mila Etropolski
Publikováno v:
Current medical research and opinion. 30(9)
This letter is intended to provide additional clarification for your readers regarding the potentially confusing issue of adverse event vs serious adverse event reporting in a recently published phase 3 study of tapentadol extended release (ER) for m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d7649c39ae782b5406db57371fcc334
https://pubmed.ncbi.nlm.nih.gov/23937387
https://pubmed.ncbi.nlm.nih.gov/23937387
Autor:
Keiichiro Imanaka, Yushin Tominaga, Etropolski, Mila, van Hove, Ilse, Masaki Ohsaka, Mikio Wanibe, Keiichiro Hirose, Taka Matsumura
Publikováno v:
Current Medical Research & Opinion; Oct2013, Vol. 29 Issue 10, p1399-1409, 11p
Autor:
Tominaga, Y., Koga, H., Uchida, N., Wanibe, M., Hirose, K., Matsumura, T., Okamoto, A., Richarz, U., Etropolski, M.
Publikováno v:
Drug Research; 2016, Vol. 66 Issue 7, p363-370, 8p
Autor:
Masatoshi Kudo
Combining harmonic technology and an ultrasound contrast agent, harmonic imaging now plays a vital role in the diagnosis and treatment of hepatic tumors. Contrast harmonic imaging is especially valuable in cases of hepatocellular carcinoma (HCC), the
